Advertisement
Screener

Cogent Biosciences, Inc. (COGT) Auditor

Cogent Biosciences, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-02-17: Fiscal year end 2025-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2025-02-25: Fiscal year end 2024-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2024-02-26: Fiscal year end 2023-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
  • 2023-03-14: Fiscal year end 2022-12-31; Auditor PricewaterhouseCoopers LLP; PCAOB firm ID 238; Location Boston, Massachusetts.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-02-172025-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsYes
2025-02-252024-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsYes
2024-02-262023-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsYes
2023-03-142022-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2022-03-152021-12-31PricewaterhouseCoopers LLP238Boston, MassachusettsNo
2021-03-162020-12-31PricewaterhouseCoopers LLPBoston, Massachusetts
2020-03-262019-12-31PricewaterhouseCoopers LLPBoston, Massachusetts
2019-03-282018-12-31PricewaterhouseCoopers LLPBoston, Massachusetts

Similar stocks

Stock NameCountryMarket CapPE Ratio
Gossamer Bio, Inc. (GOSS)United States$5.355B-0.65
Oruka Therapeutics, Inc. (ORKA)United States$5.663B-43.76
PTC THERAPEUTICS, INC. (PTCT)United States$5.199B-177.07
Travere Therapeutics, Inc. (TVTX)United States$5.712B-123.10
Mirum Pharmaceuticals, Inc. (MIRM)United States$5.798B-8.81
Dianthus Therapeutics, Inc. /DE/ (DNTH)United States$5.082B-27.79
Erasca, Inc. (ERAS)United States$5.073B-19.96
Veradermics, Inc (MANE)United States$4.839B
Amneal Pharmaceuticals, Inc. (AMRX)$6.326B25.62
Liquidia Corp (LQDA)United States$6.347B51.23